Track the Synergy CHC Corp. stock price and the full directors' dealings record of the company, a listed issuer based in United States. Shares are listed on the US market, under the oversight of SEC (Form 4). Market capitalisation: €20.9m. The latest transaction was disclosed on 24 April 2026 (Attribution). Among the most active insiders: Ross Jack. Every trade is accessible without an account.
9
Insider Decl.
n/a
Thresholds
€3m
7 ops.
Buy Volume
n/a
n/a
Sell Volume
34Σ signal
Buys €3mn/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 24,815 of 29,063 companies
26.4
score / 100
Value
9
Quality
44
FCF yld-12%
Earn yld-59%
EV/EBITDA·
ROE·
Gross mgn67%
Net mgn-41%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
300,000 shares@ US$9.0099.9% of flowCommon Stock, par value $0.00001 per shareSEC:0001474506-24-000226:0
Canonical exit: 22 Jan 2025 (T+90)
9 of 9 declarations
Acerca de Synergy CHC Corp.
Synergy CHC Corp. es una empresa que cotiza en NASDAQ, centrada en el desarrollo y la comercialización de productos de salud y bienestar. Su objetivo es proporcionar soluciones innovadoras para mejorar la calidad de vida de los consumidores.